Search

Andrew K. Bohaty

Examiner (ID: 11624, Phone: (571)270-1148 , Office: P/1786 )

Most Active Art Unit
1786
Art Unit(s)
1786, 1759, 1796, 1794
Total Applications
979
Issued Applications
602
Pending Applications
94
Abandoned Applications
318

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18628343 [patent_doc_number] => 20230287205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => DISSOLVABLE SOLID STRUCTURE HAVING FIRST AND SECOND LAYERS [patent_app_type] => utility [patent_app_number] => 18/181675 [patent_app_country] => US [patent_app_date] => 2023-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11565 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18181675 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/181675
DISSOLVABLE SOLID STRUCTURE HAVING FIRST AND SECOND LAYERS Mar 9, 2023 Pending
Array ( [id] => 19417220 [patent_doc_number] => 20240293343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applications [patent_app_type] => utility [patent_app_number] => 18/109031 [patent_app_country] => US [patent_app_date] => 2023-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17014 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18109031 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/109031
Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applications Feb 12, 2023 Pending
Array ( [id] => 18389961 [patent_doc_number] => 20230158179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/989479 [patent_app_country] => US [patent_app_date] => 2022-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41684 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17989479 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/989479
RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF Nov 16, 2022 Abandoned
Array ( [id] => 17836269 [patent_doc_number] => 20220273574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => ORGANIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/748432 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4195 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748432 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/748432
ORGANIC COMPOUNDS May 18, 2022 Abandoned
Array ( [id] => 17702959 [patent_doc_number] => 20220202965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => RADIOTRACER COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/695810 [patent_app_country] => US [patent_app_date] => 2022-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695810 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/695810
RADIOTRACER COMPOSITIONS AND METHODS Mar 14, 2022 Abandoned
Array ( [id] => 17593656 [patent_doc_number] => 20220143229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => RADIO-PHARMACEUTICAL COMPLEXES [patent_app_type] => utility [patent_app_number] => 17/581808 [patent_app_country] => US [patent_app_date] => 2022-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13026 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581808 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/581808
RADIO-PHARMACEUTICAL COMPLEXES Jan 20, 2022 Abandoned
Array ( [id] => 18253444 [patent_doc_number] => 20230080483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => MTORC MODULATORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/553409 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40730 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553409 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/553409
MTORC MODULATORS AND USES THEREOF Dec 15, 2021 Pending
Array ( [id] => 18253444 [patent_doc_number] => 20230080483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => MTORC MODULATORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/553409 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40730 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553409 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/553409
MTORC MODULATORS AND USES THEREOF Dec 15, 2021 Pending
Array ( [id] => 17671067 [patent_doc_number] => 20220184234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => METABOLIC TARGETING OF LOW GRADE TUMORS [patent_app_type] => utility [patent_app_number] => 17/537029 [patent_app_country] => US [patent_app_date] => 2021-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9633 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17537029 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/537029
METABOLIC TARGETING OF LOW GRADE TUMORS Nov 28, 2021 Abandoned
Array ( [id] => 17658456 [patent_doc_number] => 20220178921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => 4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/454300 [patent_app_country] => US [patent_app_date] => 2021-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17454300 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/454300
4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF Nov 9, 2021 Abandoned
Array ( [id] => 16930696 [patent_doc_number] => 20210196585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => BIODEGRADABLE MICROBEADS [patent_app_type] => utility [patent_app_number] => 17/199950 [patent_app_country] => US [patent_app_date] => 2021-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11276 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199950 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/199950
BIODEGRADABLE MICROBEADS Mar 11, 2021 Abandoned
Array ( [id] => 18334655 [patent_doc_number] => 20230126603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => WATER-DISPERSIBLE, OIL-FREE, AND UV-BLOCKING COSMETIC COMPOSITION AND PREPARATION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 17/798238 [patent_app_country] => US [patent_app_date] => 2021-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6213 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798238 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/798238
WATER-DISPERSIBLE, OIL-FREE, AND UV-BLOCKING COSMETIC COMPOSITION AND PREPARATION METHOD THEREFOR Feb 8, 2021 Pending
Array ( [id] => 16779410 [patent_doc_number] => 20210116488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors [patent_app_type] => utility [patent_app_number] => 17/109010 [patent_app_country] => US [patent_app_date] => 2020-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4550 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109010 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/109010
Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors Nov 30, 2020 Abandoned
Array ( [id] => 17944277 [patent_doc_number] => 20220331294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => GEL-CHEWABLE DOSAGE FORM [patent_app_type] => utility [patent_app_number] => 17/753648 [patent_app_country] => US [patent_app_date] => 2020-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4870 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753648 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/753648
GEL-CHEWABLE DOSAGE FORM Sep 14, 2020 Pending
Array ( [id] => 17850607 [patent_doc_number] => 20220280648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => DESIGN AND EFFICIENT SYNTHESIS OF LIPID-FLUORESCEIN CONJUGATES FOR CAR-T CELL THERAPY [patent_app_type] => utility [patent_app_number] => 17/625066 [patent_app_country] => US [patent_app_date] => 2020-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9133 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625066 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/625066
DESIGN AND EFFICIENT SYNTHESIS OF LIPID-FLUORESCEIN CONJUGATES FOR CAR-T CELL THERAPY Jul 1, 2020 Pending
Array ( [id] => 17748305 [patent_doc_number] => 20220226508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING EPILEPSY [patent_app_type] => utility [patent_app_number] => 17/595823 [patent_app_country] => US [patent_app_date] => 2020-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20950 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595823 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/595823
METHODS AND COMPOSITIONS FOR TREATING EPILEPSY May 27, 2020 Abandoned
Array ( [id] => 17805970 [patent_doc_number] => 20220257805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => PHARMACEUTICAL FORMULATIONS AND METHODS FOR DELIVERING A THERAPEUTIC, DIAGNOSTIC, OR IMAGING AGENT TO CD206 [patent_app_type] => utility [patent_app_number] => 17/613407 [patent_app_country] => US [patent_app_date] => 2020-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613407 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/613407
PHARMACEUTICAL FORMULATIONS AND METHODS FOR DELIVERING A THERAPEUTIC, DIAGNOSTIC, OR IMAGING AGENT TO CD206 May 19, 2020 Abandoned
Array ( [id] => 16257784 [patent_doc_number] => 20200267159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => INDEX AND METHOD OF USE OF ADAPTED FOOD COMPOSITIONS FOR DYSPHAGIC PERSONS [patent_app_type] => utility [patent_app_number] => 16/717175 [patent_app_country] => US [patent_app_date] => 2019-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6350 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16717175 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/717175
INDEX AND METHOD OF USE OF ADAPTED FOOD COMPOSITIONS FOR DYSPHAGIC PERSONS Dec 16, 2019 Abandoned
Array ( [id] => 15432131 [patent_doc_number] => 20200030248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN PARTICLE-CONTAINING CELL, AND METHOD FOR PRODUCING GELATIN PARTICLE-CONTAINING CELL [patent_app_type] => utility [patent_app_number] => 16/593141 [patent_app_country] => US [patent_app_date] => 2019-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8360 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16593141 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/593141
GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN PARTICLE-CONTAINING CELL, AND METHOD FOR PRODUCING GELATIN PARTICLE-CONTAINING CELL Oct 3, 2019 Abandoned
Array ( [id] => 17140275 [patent_doc_number] => 20210308286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => LONG-CIRCULATING PSMA-TARGETED PHOTOTHERANOSTIC AGENT [patent_app_type] => utility [patent_app_number] => 17/264220 [patent_app_country] => US [patent_app_date] => 2019-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20307 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264220 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/264220
LONG-CIRCULATING PSMA-TARGETED PHOTOTHERANOSTIC AGENT Jul 29, 2019 Abandoned
Menu